Zlatko Janeba,the head of Senior Research Group at IOCB.Dr. Zlatko Janeba earned his Ph.D. in Organic Chemistry from the Institute of Organic Chemistry and Biochemistry (IOCB) in Prague, part of the Academy of Sciences of the Czech Republic. He underwent his postdoctoral training in the groups of Prof. Morris J. Robins at Brigham Young Universityand Prof. Paul F. Torrance at Northern Arizona University.In 2005 he joined MoravekBiochemicals, Inc. in California (for 3 years), one of the leading companies in the field of custom synthesis of radiolabeled compounds for pharmaceutical research worldwide. In 2008 he rejoined the research group of Prof. Antonín Holy at IOCB and in 2010 he established his Junior Research Group within IOCB. Dr. Janeba is currently the head of Senior Research Group at IOCB, named “Targeted Analogs of Nucleic Acid Components”, where he manages the team of 13 scientists and students.Current research of the group involves design, synthesis and SAR studies of modified nucleosides and nucleotides with a wide range of biological properties, especially antiviral, anticancer, and anti-parasitic. He is a member of International Society for Antiviral Research (ISAR) and International Society of Nucleosides, Nucleotides and Nucleic Acids (IS3NA).He is an associate editor of Antiviral Chemistry & Chemotherapy. Dr. Janeba published over 70 papers with some 600 citations and h-index 14 (Web of Science).